PACS Group, Inc. (PACS) Stock
PACS has an Alpha Score of 65 out of 100 (moderate), computed on Nov 6, 2026 from 3 of 4 sub-scores. 5 of the hedge funds AlphaScala tracks reported PACS in 13F filings for the quarter ended Sep 30, 2026; the largest reported position is Marshall Wace's at $11.80M. Company insiders reported 0 open-market buys and 72 sales on SEC Form 4 in the 90 days to Nov 10, 2026. Its trailing P/E ratio is 28.4 and its net margin 4.9% (key statistics as of Nov 9, 2026).
What is PACS's Alpha Score?
How it works →Alpha Score of 65 reflects moderate overall profile with strong momentum, weak value, strong quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 6, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which hedge funds own PACS?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Marshall Wace | 277K | $11.80M | +325% |
| Citadel Ken Griffin | 144K | $6.15M | -77% |
| Hussman Investment Trust John Hussman | 84K | $3.49M | n/a |
| Millennium Management Israel Englander | 72K | $3.07M | -81% |
| D.E. Shaw David Shaw | 8K | $337.3K | -64% |
13F holdings as of Sep 30, 2026
Explore all tracked funds →Are PACS Group, Inc. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Nov 5, 26 | Murray Jason Hulse | Co-Founder, CEO & Chairman | SELL | 17.8K | $902K |
| Nov 5, 26 | Murray Jason Hulse | Co-Founder, CEO & Chairman | SELL | 1.4K | $72K |
| Nov 4, 26 | Lewis Michelle Renee | Chief Accounting Officer | SELL | 3.2K | $159K |
| Nov 4, 26 | Hancock Mark | Director | SELL | 174.9K | $8.8M |
| Nov 4, 26 | Hancock Mark | Director | SELL | 11.8K | $605K |
| Nov 4, 26 | Murray Jason Hulse | Co-Founder, CEO & Chairman | SELL | 4.0K | $190K |
| Nov 4, 26 | Murray Jason Hulse | Co-Founder, CEO & Chairman | SELL | 6.2K | $301K |
| Nov 4, 26 | Murray Jason Hulse | Co-Founder, CEO & Chairman | SELL | 12.3K | $612K |
| Nov 4, 26 | Murray Jason Hulse | Co-Founder, CEO & Chairman | SELL | 133.3K | $6.7M |
| Nov 4, 26 | Murray Jason Hulse | Co-Founder, CEO & Chairman | SELL | 11.6K | $595K |
SEC Form 4 filings as of Nov 10, 2026
See cluster-buy signals across all tickers →What are PACS's key statistics?
Key statistics as of Nov 9, 2026
How does PACS's valuation compare with the Healthcare sector?
| Metric | PACS | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 28.4 | 29.8 | 115 |
| Net margin | 4.87% | 3.60% | 175 |
| Return on equity | 25.77% | 2.93% | 201 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 11, 2026). P/E excludes loss-making companies.
PACS price chart
Powered by TradingViewWhat does PACS Group, Inc. do?
PACS Group Inc. is a holding company operating a national platform of post-acute care and senior living facilities across 17 states. The company provides skilled nursing care, assisted living, independent living, and related healthcare services through a portfolio of over 300 independently operated facilities. PACS serves patients and residents recovering from acute medical conditions, illnesses, or serious procedures who require additional care following hospital discharge. Beyond direct facility operations, the company delivers comprehensive support services to its affiliated providers, including administrative services, technology solutions, training programs, and compliance support. Founded in 2013 and headquartered in Salt Lake City, Utah, PACS operates an entrepreneurial model that balances centralized resources with local operational autonomy. The platform supports tens of thousands of daily patients and residents through a network of dedicated healthcare professionals, positioning itself as a significant player in the post-acute care sector.